Govur University Logo
--> --> --> -->
...

How does the inhibition of the cytochrome P450 system create a dangerous clinical risk for patients currently prescribed narrow-therapeutic-index medications?



The cytochrome P450 system is a family of enzymes in the liver responsible for metabolizing—or breaking down—drugs so they can be eliminated from the body. Some medications are narrow-therapeutic-index drugs, meaning the range between a dose that is effective and a dose that....

Log in to view the answer



Community Answers

Sign in to open profiles and full community answers.

No community answers yet. Be the first to submit one.

Redundant Elements